Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma

Yasunori Shikada, Ichiro Yoshino, Tatsuro Okamoto, Seiichi Fukuyama, Toshifumi Kameyama, Yoshihiko Maehara

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Purpose: The activation of Rho proteins has been shown to lead to loss of polarity in cancer cells, as well as reorganization of the cytoskeleton and facilitation of cell motility, possibly resulting in their malignant potential. The clinicopathological significance of RhoC, however, is not yet well known in the case of non-small cell lung cancer (NSCLC). Experimental Design: The intratumor expression level of RhoC mRNA was determined and compared with that in adjacent nontumorous lung tissue using quantitative reverse transcription-PCR in 49 patients with NSCLC. The relationship between the level of RhoC transcript and clinicopathological factors was examined. RhoC protein expression was confirmed by immunohistochemistry and Western blot analysis in several cases. Results: Tumor tissue of NSCLC patients demonstrated a copy number of RhoC mRNA that was well correlated with its protein level in each case and was significantly higher than that found in the corresponding nontumorous lung tissue (2.73 × 105 versus 1.13 × 10 4 copies/0.08 μg mRNA; P < 0.05). Histopathologically positive cases of lymphatic permeation showed a significantly higher copy number of RhoC than negative cases (4.31 × 105 versus 1.93 × 10 5 copies/0.08 μg mRNA; P < 0.05). With regard to venous permeation, the RhoC copy number in positive cases tended to be higher than that seen in negative cases (3.72 × 105 versus 2.14 × 105 copies/0.08 μg mRNA; P = 0.06). Conclusions: This is the first demonstration that the expression level of RhoC is correlated to vascular permeation in NSCLC.

Original languageEnglish
Pages (from-to)5282-5286
Number of pages5
JournalClinical Cancer Research
Volume9
Issue number14
Publication statusPublished - Nov 1 2003

Fingerprint

Non-Small Cell Lung Carcinoma
Messenger RNA
Lung
Proteins
Cytoskeleton
Reverse Transcription
Cell Movement
Blood Vessels
Neoplasms
Research Design
Western Blotting
Immunohistochemistry
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Shikada, Y., Yoshino, I., Okamoto, T., Fukuyama, S., Kameyama, T., & Maehara, Y. (2003). Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma. Clinical Cancer Research, 9(14), 5282-5286.

Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma. / Shikada, Yasunori; Yoshino, Ichiro; Okamoto, Tatsuro; Fukuyama, Seiichi; Kameyama, Toshifumi; Maehara, Yoshihiko.

In: Clinical Cancer Research, Vol. 9, No. 14, 01.11.2003, p. 5282-5286.

Research output: Contribution to journalArticle

Shikada, Y, Yoshino, I, Okamoto, T, Fukuyama, S, Kameyama, T & Maehara, Y 2003, 'Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma', Clinical Cancer Research, vol. 9, no. 14, pp. 5282-5286.
Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y. Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma. Clinical Cancer Research. 2003 Nov 1;9(14):5282-5286.
Shikada, Yasunori ; Yoshino, Ichiro ; Okamoto, Tatsuro ; Fukuyama, Seiichi ; Kameyama, Toshifumi ; Maehara, Yoshihiko. / Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma. In: Clinical Cancer Research. 2003 ; Vol. 9, No. 14. pp. 5282-5286.
@article{a88dc75a93484e25a193b553ca5f44f6,
title = "Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma",
abstract = "Purpose: The activation of Rho proteins has been shown to lead to loss of polarity in cancer cells, as well as reorganization of the cytoskeleton and facilitation of cell motility, possibly resulting in their malignant potential. The clinicopathological significance of RhoC, however, is not yet well known in the case of non-small cell lung cancer (NSCLC). Experimental Design: The intratumor expression level of RhoC mRNA was determined and compared with that in adjacent nontumorous lung tissue using quantitative reverse transcription-PCR in 49 patients with NSCLC. The relationship between the level of RhoC transcript and clinicopathological factors was examined. RhoC protein expression was confirmed by immunohistochemistry and Western blot analysis in several cases. Results: Tumor tissue of NSCLC patients demonstrated a copy number of RhoC mRNA that was well correlated with its protein level in each case and was significantly higher than that found in the corresponding nontumorous lung tissue (2.73 × 105 versus 1.13 × 10 4 copies/0.08 μg mRNA; P < 0.05). Histopathologically positive cases of lymphatic permeation showed a significantly higher copy number of RhoC than negative cases (4.31 × 105 versus 1.93 × 10 5 copies/0.08 μg mRNA; P < 0.05). With regard to venous permeation, the RhoC copy number in positive cases tended to be higher than that seen in negative cases (3.72 × 105 versus 2.14 × 105 copies/0.08 μg mRNA; P = 0.06). Conclusions: This is the first demonstration that the expression level of RhoC is correlated to vascular permeation in NSCLC.",
author = "Yasunori Shikada and Ichiro Yoshino and Tatsuro Okamoto and Seiichi Fukuyama and Toshifumi Kameyama and Yoshihiko Maehara",
year = "2003",
month = "11",
day = "1",
language = "English",
volume = "9",
pages = "5282--5286",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma

AU - Shikada, Yasunori

AU - Yoshino, Ichiro

AU - Okamoto, Tatsuro

AU - Fukuyama, Seiichi

AU - Kameyama, Toshifumi

AU - Maehara, Yoshihiko

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Purpose: The activation of Rho proteins has been shown to lead to loss of polarity in cancer cells, as well as reorganization of the cytoskeleton and facilitation of cell motility, possibly resulting in their malignant potential. The clinicopathological significance of RhoC, however, is not yet well known in the case of non-small cell lung cancer (NSCLC). Experimental Design: The intratumor expression level of RhoC mRNA was determined and compared with that in adjacent nontumorous lung tissue using quantitative reverse transcription-PCR in 49 patients with NSCLC. The relationship between the level of RhoC transcript and clinicopathological factors was examined. RhoC protein expression was confirmed by immunohistochemistry and Western blot analysis in several cases. Results: Tumor tissue of NSCLC patients demonstrated a copy number of RhoC mRNA that was well correlated with its protein level in each case and was significantly higher than that found in the corresponding nontumorous lung tissue (2.73 × 105 versus 1.13 × 10 4 copies/0.08 μg mRNA; P < 0.05). Histopathologically positive cases of lymphatic permeation showed a significantly higher copy number of RhoC than negative cases (4.31 × 105 versus 1.93 × 10 5 copies/0.08 μg mRNA; P < 0.05). With regard to venous permeation, the RhoC copy number in positive cases tended to be higher than that seen in negative cases (3.72 × 105 versus 2.14 × 105 copies/0.08 μg mRNA; P = 0.06). Conclusions: This is the first demonstration that the expression level of RhoC is correlated to vascular permeation in NSCLC.

AB - Purpose: The activation of Rho proteins has been shown to lead to loss of polarity in cancer cells, as well as reorganization of the cytoskeleton and facilitation of cell motility, possibly resulting in their malignant potential. The clinicopathological significance of RhoC, however, is not yet well known in the case of non-small cell lung cancer (NSCLC). Experimental Design: The intratumor expression level of RhoC mRNA was determined and compared with that in adjacent nontumorous lung tissue using quantitative reverse transcription-PCR in 49 patients with NSCLC. The relationship between the level of RhoC transcript and clinicopathological factors was examined. RhoC protein expression was confirmed by immunohistochemistry and Western blot analysis in several cases. Results: Tumor tissue of NSCLC patients demonstrated a copy number of RhoC mRNA that was well correlated with its protein level in each case and was significantly higher than that found in the corresponding nontumorous lung tissue (2.73 × 105 versus 1.13 × 10 4 copies/0.08 μg mRNA; P < 0.05). Histopathologically positive cases of lymphatic permeation showed a significantly higher copy number of RhoC than negative cases (4.31 × 105 versus 1.93 × 10 5 copies/0.08 μg mRNA; P < 0.05). With regard to venous permeation, the RhoC copy number in positive cases tended to be higher than that seen in negative cases (3.72 × 105 versus 2.14 × 105 copies/0.08 μg mRNA; P = 0.06). Conclusions: This is the first demonstration that the expression level of RhoC is correlated to vascular permeation in NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=0242694457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242694457&partnerID=8YFLogxK

M3 - Article

C2 - 14614010

AN - SCOPUS:0242694457

VL - 9

SP - 5282

EP - 5286

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 14

ER -